Gomes A S, Lois J F, Baker J D, McGlade C T, Bunnell D H, Hartzman S
Department of Radiological Sciences, UCLA Medical Center.
Radiology. 1989 Jan;170(1 Pt 1):65-8. doi: 10.1148/radiology.170.1.2909121.
A group of 145 high-risk patients who underwent angiography after administration of the nonionic contrast agent iohexol were monitored for the development of acute renal dysfunction. The results in this group were compared with those in 202 high-risk historical control subjects who had undergone angiography after administration of ionic contrast material. All patients in both groups received similar pre- and postangiographic treatment. A greater number of patients in the ionic group had preexisting renal disease, were of advanced age, and had received large volumes of contrast material. Acute renal dysfunction occurred in 20 of the 202 (10%) patients in the ionic group, compared with eight of the 145 (5.5%) patients in the nonionic group; this difference is not statistically significant. Five patients in the ionic group, but none of the patients in the nonionic group, ultimately required dialysis; this difference is not statistically significant. The findings suggest that a randomized trial in high-risk patients should be undertaken before a clinical advantage of the nonionic contrast agent iohexol with regard to renal function can be assumed.
对145例在使用非离子型造影剂碘海醇后接受血管造影的高危患者进行监测,观察急性肾功能障碍的发生情况。将该组结果与202例使用离子型造影剂后接受血管造影的高危历史对照受试者的结果进行比较。两组所有患者在血管造影前后均接受了相似的治疗。离子型组中更多患者存在既往肾脏疾病、年龄较大且接受了大量造影剂。离子型组202例患者中有20例(10%)发生急性肾功能障碍,而非离子型组145例患者中有8例(5.5%)发生;这种差异无统计学意义。离子型组有5例患者最终需要透析,而非离子型组无患者需要透析;这种差异无统计学意义。研究结果表明,在假定非离子型造影剂碘海醇在肾功能方面具有临床优势之前,应在高危患者中进行随机试验。